133 related articles for article (PubMed ID: 27329196)
1. Clinical outcomes of stage I endometrial carcinoma patients treated with surgery alone: Siriraj Hospital experiences.
Therasakvichya S; Kuljarusnont S; Petsuksiri J; Chaopotong P; Achariyapota V; Srichaikul P; Jaishuen A
J Gynecol Oncol; 2016 Sep; 27(5):e48. PubMed ID: 27329196
[TBL] [Abstract][Full Text] [Related]
2. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
Alektiar KM; Venkatraman E; Chi DS; Barakat RR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
[TBL] [Abstract][Full Text] [Related]
3. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
4. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy.
Nelson G; Randall M; Sutton G; Moore D; Hurteau J; Look K
Gynecol Oncol; 1999 Nov; 75(2):211-4. PubMed ID: 10525373
[TBL] [Abstract][Full Text] [Related]
5. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
[TBL] [Abstract][Full Text] [Related]
6. Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma.
Creutzberg CL; Nout RA; Lybeert ML; Wárlám-Rodenhuis CC; Jobsen JJ; Mens JW; Lutgens LC; Pras E; van de Poll-Franse LV; van Putten WL;
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e631-8. PubMed ID: 21640520
[TBL] [Abstract][Full Text] [Related]
7. Retrospective analysis of prognostic variables and clinical outcomes in surgically staged intermediate risk endometrial carcinoma.
Zhang GY; Wu LY; Li B; Huang MN; Zhang R; Li XG
Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):309-16. PubMed ID: 23540792
[TBL] [Abstract][Full Text] [Related]
8. Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer.
Papanikolaou A; Kalogiannidis I; Goutzioulis M; Misailidou D; Makedos A; Vergote I; Makedos G
Arch Gynecol Obstet; 2006 May; 274(2):91-6. PubMed ID: 16518607
[TBL] [Abstract][Full Text] [Related]
9. Local recurrence in high-risk node-negative stage I endometrial carcinoma treated with postoperative vaginal vault brachytherapy.
Ng TY; Perrin LC; Nicklin JL; Cheuk R; Crandon AJ
Gynecol Oncol; 2000 Dec; 79(3):490-4. PubMed ID: 11104626
[TBL] [Abstract][Full Text] [Related]
10. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
Ma SK; Zhang HT; Sun YC; Wu LY
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
[TBL] [Abstract][Full Text] [Related]
11. The long-term survival of women with surgical stage II endometrioid type endometrial cancer.
Ayhan A; Taskiran C; Celik C; Yuce K
Gynecol Oncol; 2004 Apr; 93(1):9-13. PubMed ID: 15047207
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of age in surgically staged patients with Type II endometrial carcinoma.
Vance S; Yechieli R; Cogan C; Hanna R; Munkarah A; Elshaikh MA
Gynecol Oncol; 2012 Jul; 126(1):16-9. PubMed ID: 22507535
[TBL] [Abstract][Full Text] [Related]
13. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with survival after relapse in patients with low-risk endometrial cancer treated with surgery alone.
Topfedaisi Ozkan N; Meydanlı MM; Sarı ME; Demirkiran F; Kahramanoglu I; Bese T; Arvas M; Şahin H; Haberal A; Celik H; Coban G; Oge T; Yalcin OT; Akbayır Ö; Erdem B; Numanoğlu C; Özgül N; Boyraz G; Salman MC; Yüce K; Dede M; Yenen MC; Taşkın S; Altın D; Ortaç UF; Aydın Ayık H; Şimşek T; Güngör T; Güngördük K; Sancı M; Ayhan A
J Gynecol Oncol; 2017 Sep; 28(5):e65. PubMed ID: 28657226
[TBL] [Abstract][Full Text] [Related]
15. Pathologic stage I-II endometrial carcinoma in the elderly: radiotherapy indications and outcome.
Citron JR; Sutton H; Yamada SD; Mehta N; Mundt AJ
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1432-8. PubMed ID: 15275729
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors of recurrence following adjuvant vaginal cuff brachytherapy alone for stage I endometrial cancer.
Dunn EF; Geye H; Platta CS; Gondi V; Rose S; Bradley KA; Anderson BM
Gynecol Oncol; 2014 Jun; 133(3):494-8. PubMed ID: 24657301
[TBL] [Abstract][Full Text] [Related]
17. Vaginal and pelvic recurrences in stage I and II endometrial carcinoma--survival and prognostic factors.
Blecharz P; Brandys P; Urbański K; Reinfuss M; Patla A
Eur J Gynaecol Oncol; 2011; 32(4):403-7. PubMed ID: 21941962
[TBL] [Abstract][Full Text] [Related]
18. Outcome and management of pathological stage I endometrial carcinoma patients with involvement of the lower uterine segment.
Phelan C; Montag AG; Rotmensch J; Waggoner SE; Yamada SD; Mundt AJ
Gynecol Oncol; 2001 Dec; 83(3):513-7. PubMed ID: 11733964
[TBL] [Abstract][Full Text] [Related]
19. [Multivariate analysis of prognostic factors in endometrial carcinoma].
Li B; Wu LY; Li SM; Zhang WH; Zhang R; Ma SK
Ai Zheng; 2004 Sep; 23(9):1085-8. PubMed ID: 15363208
[TBL] [Abstract][Full Text] [Related]
20. Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy.
Chadha M; Nanavati PJ; Liu P; Fanning J; Jacobs A
Gynecol Oncol; 1999 Oct; 75(1):103-7. PubMed ID: 10502434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]